Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Pfizer,Kyoto Breast Cancer Research Network
Scientific Title
Neoadjuvant hormonal therapy plus Palbociclib in operable, hormone sensitive and HER2-negative primary breast cancer